The European Commission has published a communication explaining how the principle of the free movement of goods in the EU is being applied in practice to the parallel distribution of medicinal products.
Parallel distribution is a delivery of a product from an EU / European Union Member State or from an EEA (European Economic Area) Member State that is already approved for the Bulgarian market but by an importer other than the official distributor for the country. Such imports are allowed if the product is identical to the one already authorized for sale in the Member State of destination. In order to help businesses and national administrations make full use of the internal market for medicinal products, the Commission Communication covers the rights and obligations of the stakeholders and the guarantees to which they are entitled under EU law.
Parallel trade is generally based on the principle of the free movement of goods and contributes to the development of the internal market so that more products at different prices are delivered from one national market to another.